Davis Todd C
Insider CIK 1392029 · BDSI Director · PVLA Director · PTHS Director, 10% owner · VXRT Director · LGND Chief Executive Officer, Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| LGND LIGAND PHARMACEUTICALS INC | J Other | 2026-06-30 | 2026-07-06 | 132 | $160.71 | $21.2K | 199,513 | SEC↗ |
| PTHS Pelthos Therapeutics Inc. | P Buy | 2026-06-11 | 2026-06-15 | 35,445 | $27.80 | $985.4K | 75,331 | SEC↗ |
| PTHS Pelthos Therapeutics Inc. | P Buy | 2026-06-11 | 2026-06-15 | 503 | $28.73 | $14.5K | 75,834 | SEC↗ |
| PVLA PALVELLA THERAPEUTICS, INC | A Award deriv | 2026-06-10 | 2026-06-12 | 3,000 | — | $0 | 3,000 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award deriv | 2026-03-02 | 2026-03-27 | 50,058 | — | $0 | 50,058 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award | 2026-03-02 | 2026-03-27 | 10,495 | — | $0 | 199,381 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | F Tax w/h | 2026-02-15 | 2026-02-18 | 2,805 | $183.83 | $515.6K | 188,886 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | F Tax w/h | 2026-02-15 | 2026-02-18 | 4,255 | $183.83 | $782.2K | 191,691 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | F Tax w/h | 2026-02-15 | 2026-02-18 | 2,039 | $183.83 | $374.8K | 195,946 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | F Tax w/h | 2026-02-14 | 2026-02-18 | 15,600 | $183.83 | $2.87M | 197,985 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award | 2026-02-14 | 2026-02-18 | 20,782 | — | $0 | 182,119 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | F Tax w/h | 2026-02-14 | 2026-02-18 | 8,178 | $183.83 | $1.50M | 173,941 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award | 2026-02-14 | 2026-02-18 | 39,644 | — | $0 | 213,585 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | G Gift | 2025-12-04 | 2025-12-08 | 130 | — | $0 | 161,337 | SEC↗ |
| PTHS Pelthos Therapeutics Inc. | A Award | 2025-07-02 | 2026-04-01 | 19,108 | — | $0 | 39,886 | SEC↗ |
| PTHS Pelthos Therapeutics Inc. | A Award deriv | 2025-07-02 | 2025-07-07 | 58,230 | — | $0 | 58,230 | SEC↗ |
| PTHS Pelthos Therapeutics Inc. | A Award deriv | 2025-07-02 | 2025-07-07 | 19,108 | — | $0 | 36,969 | SEC↗ |
| PTHS Pelthos Therapeutics Inc. | J Other deriv | 2025-07-01 | 2025-07-03 | 31,279 | — | $0 | 3,127,868 | SEC↗ |
| PTHS Pelthos Therapeutics Inc. | C Conversion deriv | 2025-07-01 | 2025-07-03 | 15,000 | — | $0 | 3,000 | SEC↗ |
| PTHS Pelthos Therapeutics Inc. | C Conversion | 2025-07-01 | 2025-07-03 | 1,500,000 | $10.00 | $15.00M | 1,500,000 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | J Other | 2025-06-30 | 2025-07-02 | 233 | $91.08 | $21.2K | 161,467 | SEC↗ |
| PVLA PALVELLA THERAPEUTICS, INC | A Award deriv | 2025-06-10 | 2025-06-11 | 12,350 | — | $0 | 12,350 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | P Buy | 2025-05-09 | 2025-05-13 | 5,523 | $105.67 | $583.6K | 161,234 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | P Buy | 2025-05-09 | 2025-05-13 | 2,307 | $104.53 | $241.2K | 155,711 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | P Buy | 2025-05-09 | 2025-05-13 | 1,680 | $104.57 | $175.7K | 153,404 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award deriv | 2025-03-04 | 2025-03-06 | 93,476 | — | $0 | 93,476 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award | 2025-03-04 | 2025-03-06 | 21,382 | — | $0 | 151,724 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | F Tax w/h | 2025-02-15 | 2025-02-19 | 4,255 | $120.00 | $510.6K | 130,342 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | F Tax w/h | 2025-02-15 | 2025-02-19 | 2,231 | $120.00 | $267.7K | 134,597 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award | 2025-02-14 | 2025-02-19 | 20,784 | — | $0 | 143,794 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | F Tax w/h | 2025-02-14 | 2025-02-19 | 6,966 | $120.00 | $835.9K | 136,828 | SEC↗ |
| PVLA PALVELLA THERAPEUTICS, INC | A Award deriv | 2024-12-13 | 2024-12-17 | 24,700 | — | $0 | 24,700 | SEC↗ |
| PTHS Pelthos Therapeutics Inc. | A Award | 2024-11-13 | 2026-04-01 | 4,961 | — | $0 | 20,778 | SEC↗ |
| CHRO Chromocell Therapeutics Co | A Award deriv | 2024-11-13 | 2024-11-15 | 49,605 | — | $0 | 263,306 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | P Buy | 2024-08-08 | 2024-08-09 | 2,500 | $97.39 | $243.5K | 123,010 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | J Other | 2024-06-28 | 2024-07-02 | 350 | $60.71 | $21.2K | 120,510 | SEC↗ |
| PTHS Pelthos Therapeutics Inc. | A Award | 2024-06-14 | 2026-04-01 | 12,900 | — | $0 | 15,817 | SEC↗ |
| CHRO Chromocell Therapeutics Co | A Award deriv | 2024-06-14 | 2024-06-18 | 128,977 | — | $0 | 213,701 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise deriv | 2024-03-25 | 2024-03-27 | 7,448 | — | $0 | 0 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise deriv | 2024-03-25 | 2024-03-27 | 2,156 | — | $0 | 0 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise deriv | 2024-03-25 | 2024-03-27 | 2,855 | — | $0 | 0 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise deriv | 2024-03-25 | 2024-03-27 | 3,556 | — | $0 | 0 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise | 2024-03-25 | 2024-03-27 | 3,556 | $66.19 | $235.4K | 120,160 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise | 2024-03-25 | 2024-03-27 | 2,156 | $68.51 | $147.7K | 116,604 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise | 2024-03-25 | 2024-03-27 | 2,855 | $67.24 | $192.0K | 114,448 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise | 2024-03-25 | 2024-03-27 | 7,448 | $46.20 | $344.1K | 111,593 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award deriv | 2024-02-27 | 2024-02-29 | 131,723 | — | $0 | 131,723 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award | 2024-02-27 | 2024-02-29 | 32,436 | — | $0 | 104,145 | SEC↗ |
| CHRO Chromocell Therapeutics Co | C Conversion deriv | 2024-02-21 | 2024-02-23 | 0 | — | $0 | 0 | SEC↗ |
| CHRO Chromocell Therapeutics Co | M Exercise | 2024-02-21 | 2024-02-23 | 29,167 | $4.80 | $140.0K | 29,167 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | F Tax w/h | 2024-02-15 | 2024-02-16 | 1,381 | $74.65 | $103.1K | 71,709 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | P Buy | 2023-09-22 | 2023-09-25 | 4,000 | $59.38 | $237.5K | 73,090 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | F Tax w/h | 2023-06-09 | 2023-06-13 | 420 | $73.76 | $31.0K | 69,090 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award deriv | 2023-02-23 | 2023-02-27 | 46,178 | — | $0 | 46,178 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award | 2023-02-23 | 2023-02-27 | 17,005 | — | $0 | 68,791 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award deriv | 2022-12-22 | 2022-12-27 | 2,081 | — | $0 | 2,081 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award deriv | 2022-12-05 | 2022-12-06 | 132,000 | — | $0 | 132,000 | SEC↗ |
| VXRT Vaxart, Inc. | A Award deriv | 2022-08-04 | 2022-08-08 | 44,224 | — | $0 | 44,224 | SEC↗ |
| VXRT Vaxart, Inc. | A Award | 2022-08-04 | 2022-08-08 | 7,375 | — | $0 | 125,905 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award deriv | 2022-06-10 | 2022-06-13 | 4,340 | — | $0 | 4,340 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award | 2022-06-10 | 2022-06-13 | 1,004 | — | $0 | 51,786 | SEC↗ |
| BDSI BIODELIVERY SCIENCES INTER | D To issuer deriv | 2022-03-22 | 2022-03-22 | 22,685 | — | $0 | 0 | SEC↗ |
| BDSI BIODELIVERY SCIENCES INTER | D To issuer deriv | 2022-03-22 | 2022-03-22 | 48,123 | — | $0 | 0 | SEC↗ |
| BDSI BIODELIVERY SCIENCES INTER | D To issuer deriv | 2022-03-22 | 2022-03-22 | 85,760 | — | $0 | 0 | SEC↗ |
| BDSI BIODELIVERY SCIENCES INTER | J Other | 2022-03-22 | 2022-03-22 | 252,207 | — | $0 | 0 | SEC↗ |
| BDSI BIODELIVERY SCIENCES INTER | M Exercise deriv | 2022-01-27 | 2022-02-01 | 7,684 | — | $0 | 7,685 | SEC↗ |
| BDSI BIODELIVERY SCIENCES INTER | A Award deriv | 2022-01-27 | 2022-02-01 | 15,369 | — | $0 | 15,369 | SEC↗ |
| BDSI BIODELIVERY SCIENCES INTER | A Award deriv | 2022-01-27 | 2022-02-01 | 85,760 | $3.66 | $313.9K | 85,760 | SEC↗ |
| BDSI BIODELIVERY SCIENCES INTER | M Exercise | 2022-01-27 | 2022-02-01 | 7,684 | — | $0 | 252,207 | SEC↗ |
| VXRT Vaxart, Inc. | G Gift | 2021-12-22 | 2021-12-23 | 1,470 | — | $0 | 118,530 | SEC↗ |
| BDSI BIODELIVERY SCIENCES INTER | M Exercise deriv | 2021-08-06 | 2021-08-10 | 30,000 | — | $0 | 15,000 | SEC↗ |
| BDSI BIODELIVERY SCIENCES INTER | M Exercise | 2021-08-06 | 2021-08-10 | 30,000 | — | $0 | 244,523 | SEC↗ |
| VXRT Vaxart, Inc. | A Award deriv | 2021-06-16 | 2021-06-17 | 15,097 | — | $0 | 15,097 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award deriv | 2021-06-04 | 2021-06-07 | 3,269 | — | $0 | 3,269 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award | 2021-06-04 | 2021-06-07 | 630 | — | $0 | 50,782 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise deriv | 2021-02-11 | 2021-02-12 | 2,474 | — | $0 | 0 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise | 2021-02-11 | 2021-02-12 | 2,474 | $195.91 | $484.7K | 50,152 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2021-02-10 | 2021-02-12 | 5,083 | $213.14 | $1.08M | 47,678 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise deriv | 2021-01-27 | 2021-01-27 | 2,456 | — | $0 | 0 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise | 2021-01-27 | 2021-01-27 | 2,456 | $113.50 | $278.8K | 52,761 | SEC↗ |
| BDSI BIODELIVERY SCIENCES INTER | S Sale | 2020-08-18 | 2020-08-20 | 50,000 | $4.99 | $249.5K | 217,914 | SEC↗ |
| BDSI BIODELIVERY SCIENCES INTER | M Exercise deriv | 2020-08-07 | 2020-08-11 | 30,000 | — | $0 | 45,000 | SEC↗ |
| BDSI BIODELIVERY SCIENCES INTER | M Exercise | 2020-08-07 | 2020-08-11 | 30,000 | — | $0 | 267,914 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award deriv | 2020-06-10 | 2020-06-12 | 2,468 | — | $0 | 2,468 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award | 2020-06-10 | 2020-06-12 | 831 | — | $0 | 50,305 | SEC↗ |
| VXRT Vaxart, Inc. | A Award deriv | 2020-06-08 | 2020-06-09 | 65,700 | — | $0 | 65,700 | SEC↗ |
| VXRT Vaxart, Inc. | S Sale | 2020-04-28 | 2020-04-30 | 60,000 | $3.28 | $196.8K | 120,000 | SEC↗ |
| VXRT Vaxart, Inc. | A Award deriv | 2019-11-18 | 2021-06-14 | 54,720 | — | $0 | 54,720 | SEC↗ |
| VXRT Vaxart, Inc. | A Award deriv | 2019-11-18 | 2019-11-20 | 54,720 | — | $0 | 54,720 | SEC↗ |
| BDSI BIODELIVERY SCIENCES INTER | S Sale | 2019-11-15 | 2019-11-19 | 200,000 | $6.11 | $1.22M | 237,914 | SEC↗ |
| BDSI BIODELIVERY SCIENCES INTER | M Exercise deriv | 2019-08-13 | 2019-08-15 | 18,123 | — | $0 | 75,000 | SEC↗ |
| BDSI BIODELIVERY SCIENCES INTER | M Exercise | 2019-08-13 | 2019-08-15 | 18,123 | — | $0 | 437,914 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | P Buy | 2019-08-02 | 2019-08-05 | 1,000 | $93.59 | $93.6K | 49,474 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award deriv | 2019-06-06 | 2019-06-07 | 4,071 | — | $0 | 4,071 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award | 2019-06-06 | 2019-06-07 | 835 | — | $0 | 48,474 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise deriv | 2018-10-12 | 2018-10-15 | 2,329 | — | $0 | 0 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise deriv | 2018-10-12 | 2018-10-15 | 2,754 | — | $0 | 0 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise | 2018-10-12 | 2018-10-15 | 2,754 | $89.75 | $247.2K | 45,310 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise | 2018-10-12 | 2018-10-15 | 2,329 | $119.30 | $277.8K | 47,639 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2018-10-08 | 2018-10-09 | 2,500 | $253.99 | $635.0K | 42,556 | SEC↗ |
| BDSI BIODELIVERY SCIENCES INTER | C Conversion deriv | 2018-08-24 | 2018-08-24 | 75 | — | $0 | 0 | SEC↗ |
| BDSI BIODELIVERY SCIENCES INTER | C Conversion | 2018-08-24 | 2018-08-24 | 416,667 | — | $0 | 419,791 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2018-08-17 | 2018-08-17 | 3,167 | $239.50 | $758.5K | 45,056 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2018-08-16 | 2018-08-17 | 5,833 | $239.93 | $1.40M | 48,223 | SEC↗ |
| BDSI BIODELIVERY SCIENCES INTER | M Exercise deriv | 2018-08-14 | 2018-08-16 | 3,124 | — | $0 | 93,123 | SEC↗ |
| BDSI BIODELIVERY SCIENCES INTER | M Exercise | 2018-08-14 | 2018-08-16 | 3,124 | — | $0 | 3,124 | SEC↗ |
| BDSI BIODELIVERY SCIENCES INTER | A Award deriv | 2018-08-01 | 2018-08-03 | 96,247 | — | $0 | 96,247 | SEC↗ |
| BDSI BIODELIVERY SCIENCES INTER | A Award deriv | 2018-08-01 | 2018-08-03 | 48,123 | — | $0 | 48,123 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award deriv | 2018-06-19 | 2018-07-03 | 2,474 | — | $0 | 2,474 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award deriv | 2018-06-19 | 2018-06-21 | 2,474 | — | $0 | 2,474 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award | 2018-06-19 | 2018-06-21 | 493 | — | $0 | 54,056 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2018-02-27 | 2018-02-27 | 12,335 | $151.90 | $1.87M | 53,563 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2018-02-26 | 2018-02-27 | 4,835 | $153.58 | $742.6K | 65,898 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | G Gift | 2017-12-26 | 2017-12-27 | 74 | — | $0 | 70,733 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award deriv | 2017-05-25 | 2017-05-26 | 2,456 | $113.50 | $278.8K | 2,456 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award | 2017-05-25 | 2017-05-26 | 666 | — | $0 | 70,807 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | G Gift | 2016-12-28 | 2016-12-29 | 48 | — | $0 | 70,141 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise deriv | 2016-10-31 | 2016-11-01 | 7,335 | — | $0 | 0 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise deriv | 2016-10-31 | 2016-11-01 | 3,333 | — | $0 | 0 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise deriv | 2016-10-31 | 2016-11-01 | 3,312 | — | $0 | 0 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise | 2016-10-31 | 2016-11-01 | 3,312 | $67.53 | $223.7K | 70,189 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise | 2016-10-31 | 2016-11-01 | 7,335 | $32.30 | $236.9K | 66,877 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise | 2016-10-31 | 2016-11-01 | 3,333 | $53.34 | $177.8K | 59,542 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award deriv | 2016-05-23 | 2016-05-25 | 2,329 | $119.30 | $277.8K | 2,329 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award | 2016-05-23 | 2016-05-25 | 622 | — | $0 | 56,021 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award | 2016-05-23 | 2016-05-25 | 188 | — | $0 | 56,209 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | G Gift | 2015-12-07 | 2015-12-09 | 50 | — | $0 | 55,399 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise deriv | 2015-08-06 | 2015-08-06 | 2,500 | — | $0 | 0 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise deriv | 2015-08-06 | 2015-08-06 | 7,335 | — | $0 | 0 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise deriv | 2015-08-06 | 2015-08-06 | 7,335 | — | $0 | 0 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise deriv | 2015-08-06 | 2015-08-06 | 2,500 | — | $0 | 0 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise | 2015-08-06 | 2015-08-06 | 7,335 | $12.53 | $91.9K | 55,449 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise | 2015-08-06 | 2015-08-06 | 2,500 | $17.88 | $44.7K | 38,279 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise | 2015-08-06 | 2015-08-06 | 2,500 | $8.58 | $21.4K | 40,779 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise | 2015-08-06 | 2015-08-06 | 7,335 | $10.12 | $74.2K | 48,114 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award deriv | 2015-04-24 | 2015-04-27 | 2,754 | $89.75 | $247.2K | 2,754 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award | 2015-04-24 | 2015-04-27 | 501 | — | $0 | 35,779 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award | 2015-04-24 | 2015-04-27 | 925 | — | $0 | 35,278 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award deriv | 2014-06-04 | 2014-06-05 | 3,312 | $67.53 | $223.7K | 3,312 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award | 2014-06-04 | 2014-06-05 | 666 | — | $0 | 34,353 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award | 2014-06-04 | 2014-06-05 | 1,151 | — | $0 | 33,687 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2014-03-19 | 2014-03-20 | 5,000 | $79.63 | $398.1K | 32,536 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2014-03-18 | 2014-03-20 | 2,500 | $79.45 | $198.6K | 37,536 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award deriv | 2013-06-11 | 2013-06-12 | 7,335 | $32.30 | $236.9K | 7,335 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award | 2013-06-11 | 2013-06-12 | 2,925 | — | $0 | 38,643 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award | 2013-06-11 | 2013-06-12 | 1,393 | — | $0 | 40,036 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award deriv | 2012-05-31 | 2012-05-31 | 7,335 | — | $0 | 7,335 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award | 2012-05-31 | 2012-05-31 | 2,925 | — | $0 | 32,126 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award | 2012-05-31 | 2012-05-31 | 3,592 | — | $0 | 35,718 | SEC↗ |